Kidswell Bio Corporation
JPX: 4584.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Shinya Kurebayashi
- Employees
- 38
- Headquarters
- Tokyo, Japan
- IPO year
- 2012
- Market cap
- ¥11.2B
- Website
- https://www.kidswellbio.com
Loading 4584…
Loading profile data…Frequently asked questions about 4584
What does Kidswell Bio Corporation (4584.T) do?
Kidswell Bio Corporation develops pharmaceuticals for the treatment of rare and intractable diseases in Japan. Its pipeline products include GND-004 for the treatment of ophthalmic disease and oncology; GND-007 for the treatment of immunological disease; and antibodies for oncology. The company pipeline products also include GBS-001, GBS-004, an...
Where does 4584.T trade?
Kidswell Bio Corporation (4584.T) trades on the Tokyo Stock Exchange.
What sector is 4584.T in?
Kidswell Bio Corporation (4584.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Kidswell Bio Corporation?
Shinya Kurebayashi is the chief executive officer of Kidswell Bio Corporation (4584.T).
Where is Kidswell Bio Corporation headquartered?
Kidswell Bio Corporation is headquartered in Japan.
Does 4584.T pay a dividend?
Kidswell Bio Corporation (4584.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4584.T go public?
Kidswell Bio Corporation (4584.T) completed its initial public offering in 2012.